A carregar...
CIBMTR Analysis Confirms Ongoing Role for Autologous Transplant in Chemosensitive Relapsed DLBCL
In the era of chimeric antigen receptor (CAR) T‐cell therapy for relapsed/refractory diffuse large B‐cell lymphoma (DLBCL), a new analysis from the Center for International Blood & Marrow Transplant Research (CIBMTR) confirms an ongoing role for autologous transplant in patients with chemosensit...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330917/ https://ncbi.nlm.nih.gov/pubmed/32589333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0554 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|